Article
Clinical use of Molecular Data in Thyroid Nodules and Cancer
18 May 2023
Abstract excerpt
Over the past 3 decades, advances in the molecular genetics of thyroid cancer (TC) have been translated into diagnostic tests, prognostic markers, and therapeutic agents. The main drivers in differentiated TC pathogenesis are single-point mutations and gene fusions in components of the Mitogen-activated protein kinase (MAPK) and phosphoinositide-3-kinase-protein kinase B/Akt (PI3K/Akt) pathways. Other important...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
